10 likes | 142 Vues
Recent advances in cancer treatments have significantly improved survival rates, with 5-year relative survival rates showing a marked increase. According to research, the surge in the number of cancer drugs since 1975 accounts for 50%–60% of the rise in age-adjusted survival rates. This highlights the critical role that innovation in pharmaceuticals plays in enhancing patient outcomes. Notably, survival rates are adjusted for expected normal life expectancy, ensuring a more accurate assessment of the effectiveness of cancer treatments.
E N D
Cancer Survival Increasing Advances in cancer treatments have contributed to an increase in survival rates 5-Year Relative Survival Rates for Cancers in U.S.1 “ Increases in the number of cancer drugs since 1975 account for 50%–60% of the increase in age-adjusted survival rates.2 – F. Lichtenberg, Columbia University “ Note: Survival rates are adjusted for normal life expectancy. Sources: 1Ries LAG et al. (eds). “SEER Cancer Statistics Review, 1975-2005,” National Cancer Institute, based on November 2007 SEER data submission, posted to the SEER web site, 2008; 2F. Lichtenberg, “The Expanding Pharmaceutical Arsenal in the War on Cancer,” NBER Working Paper 10328, 2004.